Beyond market averages, investors seeking exceptional growth focus on the art of stock selection. The right picks can significantly contribute to the expansion of your wealth.
In the latest session, Galmed Pharmaceuticals Ltd (NASDAQ: GLMD) closed at $0.75 down -0.38% from its previous closing price of $0.75. In other words, the price has decreased by -$0.38 from its previous closing price. On the day, 86791.0 shares were traded. GLMD stock price reached its highest trading level at $0.7909 during the session, while it also had its lowest trading level at $0.7351.
Ratios:
For a deeper understanding of Galmed Pharmaceuticals Ltd’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 7.98 and its Current Ratio is at 7.98. In the meantime, Its Debt-to-Equity ratio is 0.00 whereas as Long-Term Debt/Eq ratio is at 0.00.
Upgrades & Downgrades
. In the most recent recommendation for the company, B. Riley FBR on May 22, 2020, Downgraded its rating to Neutral and sets its target price to $8 from $11 previously.
On February 04, 2020, Craig Hallum started tracking the stock assigning a Buy rating and target price of $18.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, GLMD now has a Market Capitalization of 4112163 and an Enterprise Value of -14938837.
Stock Price History:
The Beta on a monthly basis for GLMD is 0.34, which has changed by -0.77319276 over the last 52 weeks, in comparison to a change of 0.17511821 over the same period for the S&P500. Over the past 52 weeks, GLMD has reached a high of $3.61, while it has fallen to a 52-week low of $0.74. The 50-Day Moving Average of the stock is -30.21%, while the 200-Day Moving Average is calculated to be -47.92%.
Shares Statistics:
For the past three months, GLMD has traded an average of 2.07M shares per day and 86210 over the past ten days. A total of 5.48M shares are outstanding, with a floating share count of 5.41M. Insiders hold about 1.19% of the company’s shares, while institutions hold 4.49% stake in the company. Shares short for GLMD as of 1765756800 were 103943 with a Short Ratio of 0.05, compared to 1763078400 on 1321. Therefore, it implies a Short% of Shares Outstanding of 103943 and a Short% of Float of 1.9199998999999999.
Earnings Estimates
The company has 1 analysts who recommend its stock at the moment.
Analysts are recommending an EPS of between -$2.31 and -$2.31 for the fiscal current year, implying an average EPS of -$2.31. EPS for the following year is -$0.85, with 1.0 analysts recommending between -$0.85 and -$0.85.
